As shown on the slide, the endogenous opioid system exists in balance, with the three receptors mediating opposing components of the affective system of the brain.[1,6] Of course, the view that the mu- and kappa- opioid receptor systems are mutually antagonistic is overly simplistic; there is some evidence that in some regions of the brain these systems can work synergistically.[6] The endogenous opioid system can be seen – rather than as a balance of kappa versus mu activation – as a complex counter-balanced interacting system determined by genetics, by the expression, localisation, and regulation of opioid receptors, and by their interaction with different neurochemical systems.[6] When considered in its full intricacy, correcting an imbalance in the opioid system is far more complicated than adjusting one side or the other.[6]

References:
[1] Nutt DJ, Nestor LJ. The Opioid System and Addiction. In: Nutt DJ, Nestor LJ (eds). Addiction, 2nd edition. Oxford University Press, 2018.

[2] Stahl SM. Stahl’s Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. 4th edition. © Cambridge University Press, 2013.

[3] Ramchandani VA, Umhau J, Pavon FJ, et al. A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry 2011; 16 (8): 809–817.

[4] Pan ZZ. mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci 1998; 19 (3): 94–98.

[5] Zhao J, Xin X, Xie GX, et al. Molecular and cellular mechanisms of the age-dependency of opioid analgesia and tolerance. Mol Pain 2012; 8: 38.

[6] Emery MA, Akil H. Endogenous opioids at the intersection of opioid addiction, pain, and depression: the search for a precision medicine approach. Annu Rev Neurosci 2020; 43: 355–374.